Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Camellia hemostatic medicine

A technology of hemostatic medicine and camellia, which is applied in the field of preparation of Chinese patent medicine for external use, can solve problems such as unsatisfactory hemostatic effect, complicated formula, slow wound healing, etc.

Active Publication Date: 2015-06-03
湖南油谷高科技有限公司
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many kinds of existing hemostatic drugs, each of which has its own advantages and limitations: some have complex formulas and dozens of drugs in combination; some contain toxic ingredients; also slower to heal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Camellia hemostatic medicine
  • Camellia hemostatic medicine
  • Camellia hemostatic medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] The camellia hemostatic medicine of the present embodiment is prepared from the following raw materials in parts by weight:

[0051] Fresh camellia 45 Camellia oil 7 Chitosan 18

[0052] Arborvitae leaves 5 Incense ash 5 Vitamin K 1.5

[0053] Calcium Alginate 4 Licorice 5 Tea Saponin 1.5;

[0054] Its preparation process is as follows:

[0055] (1) Prepare raw materials: according to the above parts by weight, take each raw material respectively, for subsequent use;

[0056] 2. Raw material pretreatment:

[0057] ①. Fresh camellia pretreatment: Put the fresh camellia without pests into clean water to wash 4 times, remove it, grind it into 80-mesh fine material, then press filter, collect the camellia filtrate and camellia filter residue respectively, and set aside; The Camellia filter residue was mixed with 3 times its weight and 65% edible ethanol at 5°C, left to stand for 4 hours, and stirred clockwise every 30 minutes for 4 minutes, filtered, and the alcohol-ext...

Embodiment 2

[0066] The camellia hemostatic medicine of the present embodiment is prepared from the following raw materials in parts by weight:

[0067] Fresh camellia 65 Camellia oil 4 Chitosan 10

[0068] Arborvitae leaves 10 Incense ash 2 Vitamin K 3.5

[0069] Calcium Alginate 1 Licorice Root 2 Tea Saponin 0.4.

[0070] Others are the same as in Embodiment 1.

Embodiment 3

[0072] The camellia hemostatic medicine of the present embodiment is prepared from the following raw materials in parts by weight:

[0073] Fresh camellia 55 Camellia oil 6 Chitosan 15

[0074] Arborvitae leaves 8 Incense ash 4 Vitamin K 2.5

[0075] Calcium Alginate 3 Licorice 4 Tea Saponin 1.

[0076] Others are the same as in Embodiment 1.

[0077] The camellia hemostatic medicine of the invention is suitable for hemostasis of various wounds.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a camellia hemostatic medicine, and relates to the technical field of external Chinese patent medicines. The camellia hemostatic medicine is prepared from the following raw materials in parts by weight: 45-65 parts of fresh camellia, 4-7 parts of tea oil, 10-18 parts of chitosan, 5-10 parts of cacumen biotae, 2-5 parts of incense ashes, 1.5-3.5 parts of vitamin K, 1-4 parts of calcium alginate, 2-5 parts of liquorice and 0.4-1.5 parts of tea saponin. The camellia hemostatic medicine is prepared by the following preparation processes: 1 preparing raw materials; 2 pretreating the raw materials, namely (1) pretreating fresh camellia, (2) pretreating liquorice, (3) pretreating incense ashes, and (4) pretreating cacumen biotae; and 3 preparing, namely A, primarily mixing, B, secondarily mixing, and C, homogenizing. The camellia hemostatic medicine has the efficacies of cooling blood, stopping bleeding, diminishing inflammation, easing pain, and promoting normal solidification of blood, has the characteristics of good biological degradability and biocompatibility, and is suitable for stopping bleeding for kinds of wounds.

Description

technical field [0001] The invention relates to the technical field of preparation of Chinese patent medicine for external use, in particular to a camellia hemostatic medicine. Background technique [0002] In daily life, we often encounter situations that require rapid local hemostasis, especially in emergency treatment of sudden accidents, trauma hemostasis during surgery is very important. There are many kinds of existing hemostatic drugs, each of which has its own advantages and limitations: some have complex formulas and dozens of drugs in combination; some contain toxic ingredients; Healing is also slower. [0003] The "astringent and hemostatic drug" disclosed in the Chinese patent (application number 201010500268.3) is prepared by a conventional method and consists of the following raw materials in parts by weight: 5 parts of Direncao, 2 parts of Panax notoginseng, 4 parts of Camellia japonica, 3 parts of Equisetum, 5 parts of Artemisia argyi, 5 parts of Baicao Cre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/82A61K9/14A61P7/04A61K31/722A61K31/702
Inventor 管天球王宋辉
Owner 湖南油谷高科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products